With over 100 million US adults experiencing obesity, and the condition accounting for $173 billion dollars in extra health costs annually, health tech company Theator set out to examine how bariatric surgeries are stacking up, only to find ...
Mazdutide demonstrates its differentiated advantages as a novel dual agonist of GLP-1 and GCG receptor with superior weight loss efficacy, significant improvement in a series of cardiometabolic indicators (waist circumferenc e, ...
WASHINGTON , Oct. 10, 2023 /PRNewswire/ -- Live-stream and In Person Event, October 11 , 2:00 – 4:00 PM, ET National Press Club, Washington DC , or live stream – register here: The State of Obesity: Creating Pathways to a ...
AD-9308 is a potent, and highly selective oral ALDH2 activator ready for IND-enabling development. AD-9308 treatment ameliorates diet-induced obesity and fatty liver, and improves glucose homeostasis in both male Aldh2 wild-type and Aldh2 ...
New patent covers methods to treat obesity using phenotyping. MENLO PARK, Calif. , Sept. 28, 2023 /PRNewswire/ -- Phenomix Sciences (Phenomix), a precision medicine biotechnology company that brings data-driven precision medicine ...
COPENHAGEN, Denmark , Aug. 30, 2023 /PRNewswire/ -- Embark Laboratories announced today that Novo Nordisk has acquired Embark Biotech, including its lead metabolic program, and has entered a three-year research and development collaboration ...
TAMPA, Fla. , July 20, 2023 /PRNewswire/ -- The Obesity Action Coalition (OAC) applauds Senators Tom Carper (D-DE) and Bill Cassidy (R-LA) and Representatives Brad Wenstrup (R-OH), Raul Ruiz (D-CA), Mariannette Miller-Meeks ...
The latest oral swab is the first to help providers determine the most effective treatment for the Hungry Brain phenotype which, together with Hungry Gut, affects 64% of obesity patients and are the primary phenotypes that cause obesity. ...
ROCKVILLIE, Md. and SUZHOU, China , May 10, 2023 /PRNewswire/ -- Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the ...
Adequately dosed lifestyle interventions?may unilaterally achieve success but are too often not adequately dosed, the statement says. ST. LOUIS , April 20, 2023 /PRNewswire-PRWeb/ -- The American College of Lifestyle Medicine (ACLM) has ...
Understanding how brain chemistry and food decisions are linked to rising obesity and related health issues.
Study finds a 50% rise in overweight and obesity among adolescents in England, increasing from 22% in 2008–2010 to 33% in 2021–2023.
The increasing use of GLP-1 medications for weight loss is leading to significant changes in food preferences, with users consuming less processed foods, soda, and certain meats.
Losing a lot of weight provides long-term health benefits, even if some weight is regained.
A new study links childhood overweight and obesity to higher COPD risk, stressing early weight management for lung health.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are provided for informational and educational purposes only. They should NOT be used for the diagnosis or treatment of any health-related condition or disease. Always consult a qualified healthcare professional for medical advice, diagnosis, or treatment. Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers